» Articles » PMID: 500824

Attenuation of Angiotensin II- and III-induced Aldosterone Release by Prostaglandin Synthesis Inhibitors

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1979 Dec 1
PMID 500824
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of two prostaglandin synthesis inhibitors, indomethacin and meclofenamate, on angiotensin II (AII)- and III (AIII)-induced aldosterone release was studied in normal and sodium-depleted conscious rats and in adrenal capsular cell suspensions obtained from normal rats. In normal rats, in vivo AII and AIII were equipotent in causing dose-related increases in serum aldosterone concentrations. Indomethacin decreased the basal serum aldosterone levels by 50% and serum renin levels by 43%. In addition, the steroidogenic effects of AII and AIII were reduced by 45 and 63% with 3 mg/kg of indomethacin and 63 and 73% with 10 mg/kg, respectively. In contrast, meclofenamate failed to alter basal serum levels of aldosterone or AII-stimulated aldosterone release but inhibited serum renin levels by 27% and the aldosterone-stimulating effect of AIII by 99%. Indomethacin (3 mg/kg) and meclofenamate (2 mg/kg) inhibited urinary prostaglandin (PG)E(2) and PGF(2alpha) excretion by 63 and 52% and 37 and 31%, respectively. Both inhibitors significantly decreased the adrenal capsular PGE(2) and PGF(2alpha) content and the conversion of [(14)C]arachidonate to [(14)C]PGE(2) and [(14)C]PGF(2alpha). In sodium-depleted rats, indomethacin produced similar effects reducing the control serum aldosterone levels by 29%, AII-stimulated aldosterone by 47%, and completely suppressing the aldosterone response to AIII without altering serum renin activity. In adrenal cell suspensions, similar results were observed with indomethacin inhibiting basal and AII- and AIII-stimulated aldosterone release by 29, 81, and 93%, respectively. Meclofenamate failed to alter basal and AII-stimulated aldosterone release but inhibited that stimulated by AIII by 86%. The present findings suggest that prostaglandins modulate the effects of the renin-angiotensin system by stimulating the release of renin from the kidney and augmenting the steroidogenic effects of AII and AIII in the adrenal cortex.

Citing Articles

An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers.

Maideen N, Balasubramanian R, Muthusamy S, Nallasamy V Curr Cardiol Rev. 2022; 18(6):e110522204611.

PMID: 35546745 PMC: 9893153. DOI: 10.2174/1573403X18666220511152330.


Effects of NSAIDs on kidney functions and cardiovascular system.

Sener Y, Oksul M J Clin Hypertens (Greenwich). 2020; 22(2):302.

PMID: 31913564 PMC: 8029895. DOI: 10.1111/jch.13769.


Hyporeninemic hypoaldosteronism in a patient with diabetes mellitus: an unforgettable case report.

Chelaghma N, Oyibo S Int Med Case Rep J. 2018; 11:69-72.

PMID: 29662328 PMC: 5892611. DOI: 10.2147/IMCRJ.S158628.


Hyperkalemia in the Hypertensive Patient.

Lakkis J, Weir M Curr Cardiol Rep. 2018; 20(2):12.

PMID: 29492706 DOI: 10.1007/s11886-018-0954-2.


Drug-induced impairment of renal function.

Pazhayattil G, Shirali A Int J Nephrol Renovasc Dis. 2014; 7:457-68.

PMID: 25540591 PMC: 4270362. DOI: 10.2147/IJNRD.S39747.


References
1.
Campbell W, Graham R, Jackson E . Role of renal prostaglandins in sympathetically mediated renin relase in the rat. J Clin Invest. 1979; 64(2):448-56. PMC: 372139. DOI: 10.1172/JCI109482. View

2.
Spat A, Siklos P, Antoni F, Nagy K, Sziranyi K . Effect of prostaglandin synthetase inhibitors of basal and ACTH-stimulated steroid synthesis by separated adrenocortical zones. J Steroid Biochem. 1977; 8(4):293-8. DOI: 10.1016/0022-4731(77)90022-x. View

3.
Blumberg A, Nishikawa K, Denny S, Marshall G, NEEDLEMAN P . Angiotensin (A I, A II, A III) receptor characterization. Correlation of prostaglandin release with peptide degradation. Circ Res. 1977; 41(2):154-8. DOI: 10.1161/01.res.41.2.154. View

4.
Devynck M, Pernollet M, Matthews P, Khosla M, BUMPUS F, Meyer P . Specific receptors for des-Asp1-angiotensin II (("angiotensin III") in rat adrenals. Proc Natl Acad Sci U S A. 1977; 74(9):4029-32. PMC: 431830. DOI: 10.1073/pnas.74.9.4029. View

5.
Honn K, CHAVIN W . Role of prostaglandins in aldosterone production by the human adrenal. Biochem Biophys Res Commun. 1976; 72(4):1319-26. DOI: 10.1016/s0006-291x(76)80159-3. View